To investigate the potential involvement of autophagy in adverse cardiac hypertrophy, we initially assessed the level of autophagy in the hearts of TAC mice and in neonatal cardiomyocytes treated with ET-1. Here, EDN1 is linked to cardiac hypertrophy.